How The European Medicines Agency Inspected Thermo Fisher’s Florida Plant Without Leaving Europe
Executive Summary
Contract development and manufacturing organization relied on combination of immersive mixed-reality devices to host remote inspection.
You may also be interested in...
ICMRA Review Finds Remote Alternatives Could Complement Onsite Inspections, Not Replace Them
Stance echoes US FDA’s view that remote alternatives should be “supplemental tools” to support in-person inspections.
World’s Pharmaceutical Inspectorates Prepare For Post-Pandemic Remote Site Assessments
US, EU, global authorities share experiences, insights, advice for industry on remote alternatives even after inspectors can resume travels.
Preparing For The Return Of US FDA Inspections
Compared to FY2019, FDA data show agency inspections of OTC and Rx drug manufacturing facilities in FY2020 fell 60%. As pandemic continues in FY2021, inspection rate will remain depressed, and it remains unclear how the agency will reduce the backlog without resorting to remotely conducted inspections.